neobookRx

Volatile Solvents

Description Diagnostic criteria General and supportive measures Medicine treatment Referral ICD-10 code:  T53 DESCRIPTION Inhalants include: spray-paint, glue and paint thinners that may contain hydrocarbons such as toluene and/or n-Hexane. If these are ingested, hydrocarbon poisoning with possible chemical pneumonitis must also be considered. DIAGNOSTIC CRITERIA distinctive odour, euphoria,

Description

Diagnostic criteria

General and supportive measures

Medicine treatment

Referral


ICD-10 code: T53

DESCRIPTION

Inhalants include: spray-paint, glue and paint thinners that may contain hydrocarbons such as toluene and/or n-Hexane. If these are ingested, hydrocarbon poisoning with possible chemical pneumonitis must also be considered.

DIAGNOSTIC CRITERIA

  • distinctive odour,
  • euphoria,
  • discolouration around mouth/nose,
  • headaches,
  • palpitations,
  • progressive CNS depression,
  • dizziness,
  • syncope,
  • cardiac arrhythmias,
  • hypokalaemia,
  • mucous membrane irritation, i.e. sneezing, coughing and tearing,
  • GIT complaints, i.e. nausea, vomiting and abdominal pain,
  • distal renal tubular acidosis, i.e. hyperchloraemic metabolic acidosis with a normal anion gap.
  • Complications include peripheral neuropathy and hepatotoxicity.

GENERAL AND SUPPORTIVE MEASURES

  • Stabilise airway, breathing and circulation.
  • Perform a chest X-ray if respiratory symptoms present.
  • Monitor patient for respiratory symptoms: if absent after 6–8 hours, child can be discharged.
  • Correct fluid and electrolyte abnormalities.

MEDICINE TREATMENT

For agitation:

  • Diazepam, IV/oral, 0.1–0.2 mg/kg.
    • Maximum dose: 10 mg.

For cardiac dysrhythmias, e.g. ventricular fibrillation, see: Cardiovascular System, Cardiac dysrhythmias.

REFERRAL

  • Cardiac dysrhythmia.

Standard Treatment Guidelines and Essential Medicines List for South Africa, Hospital Level, Paediatrics, 2023 Edition

Chapter 18: Poisoning,  18.1 Poisoning,  18.1.5 Volatile Solvents

Drugs mentioned

NeoHealth® ID 19841 · updated 5/29/2023